These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8917410)

  • 1. Improvement of intestinal toxicity of 5-fluorouracil by conagenin, a low molecular immunomodulator.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    Anticancer Res; 1996; 16(5A):2937-41. PubMed ID: 8917410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by conagenin of inflammatory mediator productions in mice given 5-fluorouracil.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    Anticancer Res; 1997; 17(2A):917-22. PubMed ID: 9137428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.
    Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M
    Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model.
    Wu Z; Han X; Qin S; Zheng Q; Wang Z; Xiang D; Zhang J; Lu H; Wu M; Zhu S; Yu Y; Wang Y; Han W
    Biomed Pharmacother; 2010 Nov; 64(9):589-93. PubMed ID: 20888173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of efficacy of antitumor agents by conagenin.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1995 Mar; 48(3):222-5. PubMed ID: 7730156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus.
    Lucchinetti CF; Kimmel DW; Pavelko K; Rodriguez M
    Exp Neurol; 1997 Sep; 147(1):123-9. PubMed ID: 9294409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diamine oxidase as blood biomarker in rats and humans to GI tract toxicity of fluorouracil anti-cancer drugs].
    Goto T; Matsubara T; Yoshizawa Y; Sasaya S; Nemoto H; Sanada Y; Moriyama K; Kouchi Y
    Gan To Kagaku Ryoho; 2011 May; 38(5):765-9. PubMed ID: 21566434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of medroxyprogesterone acetate on antitumor efficacies and side effect of 5-fluorouracil].
    Ashizawa T; Ishida H; Okabe M; Gomi K
    Gan To Kagaku Ryoho; 1993 May; 20(7):941-7. PubMed ID: 8489300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
    Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
    Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon.
    Sakai H; Sagara A; Matsumoto K; Jo A; Hirosaki A; Takase K; Sugiyama R; Sato K; Ikegami D; Horie S; Matoba M; Narita M
    Pharmacol Res; 2014 Sep; 87():71-9. PubMed ID: 24972040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
    Chandrashekar NS; Shobha Rani RH
    J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of p53-independent apoptosis in the intestinal toxicity induced by raltitrexed (ZD1694, Tomudex): genetic differences between BALB/c and DBA/2 mice.
    Pritchard DM; Bower L; Potten CS; Jackman AL; Hickman JA
    Clin Cancer Res; 2000 Nov; 6(11):4389-95. PubMed ID: 11106258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
    Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of uridine treatment in mice on the protection of gastrointestinal toxicity caused by 5-fluorouracil.
    Bagrij T; Kralovanszky J; Gyergyay F; Kiss E; Peters GJ
    Anticancer Res; 1993; 13(3):789-93. PubMed ID: 8317913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice.
    Sezaki T; Hirata Y; Hagiwara T; Kawamura YI; Okamura T; Takanashi R; Nakano K; Tamura-Nakano M; Burkly LC; Dohi T
    World J Gastroenterol; 2017 Apr; 23(13):2294-2307. PubMed ID: 28428709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.